# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5188175 | DDO-2213 | IC50 | = | 29 | nM | ALA5165196 | 7.54 | nM | Homo sapiens | ||
2. | ALA3798088 | 3; MM-401 | IC50 | = | 0.9 | nM | ALA4186848 | 9.05 | nM | Homo sapiens | ||
3. | Rabeprazole | LY-307640 | INH | = | 50 | % | ALA4683561 | % | Homo sapiens | |||
4. | Rabeprazole | LY-307640 | INH | = | 50 | % | ALA4683560 | % | Homo sapiens | |||
5. | Dexlansoprazole | DEXLANSOPRAZOLE | IC50 | = | 5.7 | uM | ALA4683559 | 5.24 | nM | Homo sapiens | ||
6. | Lansoprazole | 1 (Lansoprazole(Takeda)) | IC50 | = | 5.9 | uM | ALA4683559 | 5.23 | nM | Homo sapiens | ||
7. | ALA1201320 | 22, esomeprazole | IC50 | = | 1.8 | uM | ALA4683559 | 5.75 | nM | Homo sapiens | ||
8. | Omeprazole | 1 (Omeprazole (Hassle)) | IC50 | = | 1.7 | uM | ALA4683559 | 5.77 | nM | Homo sapiens | ||
9. | Rabeprazole | LY-307640 | IC50 | = | 0.49 | uM | ALA4683559 | 6.31 | nM | Homo sapiens | ||
10. | ALA4741363 | 8 | IC50 | > | 100 | uM | ALA4683559 | nM | Homo sapiens | |||
11. | ALA4792444 | 7 | IC50 | > | 100 | uM | ALA4683559 | nM | Homo sapiens | |||
12. | ALA50030 | 22 | IC50 | > | 100 | uM | ALA4683559 | nM | Homo sapiens | |||
13. | ALA4789713 | 5 | IC50 | > | 100 | uM | ALA4683559 | nM | Homo sapiens | |||
14. | ALA4783399 | 4 | IC50 | > | 100 | uM | ALA4683559 | nM | Homo sapiens | |||
15. | ALA4798671 | 3 | IC50 | > | 100 | uM | ALA4683559 | nM | Homo sapiens | |||
16. | ALA4741681 | 2 | IC50 | = | 1.7 | uM | ALA4683559 | 5.77 | nM | Homo sapiens | ||
17. | ALA10184 | 5-desmethoxyomeprazole | IC50 | = | 1.1 | uM | ALA4683559 | 5.96 | nM | Homo sapiens | ||
18. | ALA3885241 | 30 | INH | 0 | ALA4683558 | Active | % | Homo sapiens | ||||
19. | ALA3885241 | 30 | INH | 0 | ALA4683557 | Active | % | Homo sapiens | ||||
20. | Rabeprazole | LY-307640 | INH | 0 | ALA4683556 | Dose-dependent effect | % | Homo sapiens |